Healthcare marketing platform Doceree is introducing a new intelligence layer designed to help pharmaceutical brands engage healthcare professionals based on real-time clinical behavior rather than historical prescribing patterns. Called Clinical Intent Signals (CIS), the technology aims to provide healthcare marketers with a new way to identify and activate physician intent across digital channels, potentially reshaping how omnichannel healthcare campaigns are planned, targeted, and measured.

The healthcare marketing industry has long faced a fundamental challenge: understanding what healthcare professionals are considering today rather than what they prescribed weeks or months ago.

Doceree believes it has a solution.

The company announced the launch of Clinical Intent Signals (CIS), a real-time intelligence layer designed to detect, interpret, and activate physician intent signals across healthcare engagement channels. The technology will become commercially available through Doceree's upcoming Daily Command Marketplace, scheduled to launch publicly on July 14, 2026.

The announcement represents an important development in healthcare marketing technology because it introduces intent-based marketing capabilities to a sector that has historically relied on retrospective data, static audience segmentation, and delayed prescribing insights.

In consumer and B2B marketing, intent data has become a foundational component of audience targeting and campaign orchestration. Marketers routinely use behavioral signals such as search activity, content consumption, website engagement, and purchase research patterns to identify buyers who are actively evaluating products or services.

Healthcare marketing has largely been excluded from this transformation.

Regulatory requirements, privacy constraints, fragmented data ecosystems, and the complexity of clinical workflows have traditionally limited marketers' ability to identify real-time physician decision-making signals.

Doceree's Clinical Intent Signals platform seeks to bridge that gap.

According to the company, CIS analyzes digital interactions associated with healthcare professional research and clinical evaluation processes, including medical content consumption, guideline lookups, journal engagement, workflow interactions, and therapeutic-area research activity. These signals are then translated into actionable intent stages that can be activated across advertising, email marketing, field sales engagement, physician education initiatives, and patient support programs.

The company emphasizes that the system operates within privacy-first and PHI-compliant frameworks, relying on verified healthcare professional-level signals rather than patient-level information.

For healthcare marketers, the implications could be significant.

Traditional healthcare marketing often relies heavily on prescription data, claims information, and historical physician behavior to identify potential audiences. While valuable, those datasets frequently reflect actions that have already occurred. Clinical Intent Signals is designed to identify decision-making activity earlier in the process, potentially enabling pharmaceutical brands to engage physicians before prescribing patterns become visible through conventional reporting systems.

This shift reflects a broader trend occurring across enterprise marketing technology.

Major platforms from Salesforce, Adobe, Google, and Microsoft have increasingly focused on intent-driven customer engagement models that enable organizations to personalize messaging based on real-time behavioral signals.

Doceree is applying a similar philosophy to healthcare marketing.

The launch is also closely tied to Daily Command, the company's new operational platform designed to serve as a centralized command layer for healthcare marketers. Through the Daily Command Marketplace, organizations will be able to integrate Clinical Intent Signals with existing demand-side platforms (DSPs), customer relationship management systems, marketing automation platforms, sales engagement tools, and omnichannel orchestration environments.

According to Doceree, early pilot results suggest measurable performance improvements.

The company reported findings from a 12-week pilot involving approximately 36,000 matched healthcare professionals across multiple therapeutic categories. Campaigns leveraging Clinical Intent Signals achieved a 38% faster progression through physician decision stages, a 27% increase in contextual engagement rates, and a 21% improvement in media efficiency compared with control groups.

While these results were generated under pilot conditions, they highlight growing interest in intent-based healthcare engagement strategies.

Industry analysts have increasingly pointed to personalization and real-time engagement as major priorities for life sciences organizations. Research from Forrester indicates that organizations leveraging behavioral intelligence and contextual engagement strategies often achieve stronger campaign performance and more efficient customer acquisition outcomes. Similarly, Gartner has identified AI-powered decision intelligence as a critical area of investment across marketing and commercial operations.

What makes the announcement particularly notable is its potential impact on omnichannel healthcare marketing.

Many pharmaceutical organizations continue to operate separate systems for digital advertising, field sales engagement, physician education, email marketing, and patient support programs. By introducing a unified intent signal that can operate across these channels, Doceree is attempting to create a more coordinated approach to healthcare engagement.

The broader opportunity extends beyond campaign performance.

As healthcare marketers seek more precise, privacy-compliant ways to engage physicians, intent intelligence could become a foundational layer within future healthcare marketing stacks. Similar to how customer data platforms transformed audience management in enterprise marketing, clinical intent platforms may emerge as a new category focused on understanding physician decision-making in real time.

If adoption grows, Clinical Intent Signals could mark the beginning of a larger shift from audience-based healthcare marketing to intent-driven healthcare engagement.

Market Landscape

Healthcare marketing technology is rapidly evolving as pharmaceutical companies seek more personalized and measurable engagement strategies. Traditional audience segmentation models are increasingly being supplemented by behavioral intelligence, AI-powered analytics, and omnichannel orchestration platforms.

According to research from Gartner and Forrester, investments in AI-enabled decision intelligence, predictive analytics, and real-time customer engagement technologies continue to accelerate across life sciences organizations. Meanwhile, the growing adoption of digital physician engagement channels is creating demand for more sophisticated targeting and measurement capabilities.

The emergence of clinical intent intelligence platforms reflects a broader industry movement toward contextual engagement models that prioritize timing, relevance, and behavioral signals over static audience classifications.

Top Insights

• Doceree launched Clinical Intent Signals, a new intelligence layer designed to identify and activate physician intent across healthcare marketing channels in real time.
• The platform enables pharmaceutical marketers to move beyond retrospective prescribing data and engage healthcare professionals during active clinical decision-making processes.
• Clinical Intent Signals integrates with advertising platforms, CRM systems, marketing automation tools, and sales engagement environments through the Daily Command Marketplace.
• Pilot programs involving 36,000 healthcare professionals demonstrated improvements in engagement, media efficiency, and progression through physician decision journeys.
• The launch introduces intent-based marketing principles to healthcare, a capability long established in B2B and consumer marketing but historically difficult to implement in regulated healthcare environments.

Get in touch with our MarTech Experts